This week we will be presenting our novel debridement agent that addresses the biofilm in chronic wounds during the World Union of Wound Healing Societies 2022 Hybrid Congress in Abu Dhabi.
This morning Michel Hermans MD, medical consultant to DEBx Medical, hosted a talk named “Speedy removal of necrosis and biofilm with a hygroscopic chemical debriding compound.”
Tomorrow the 3rd of March, our CEO, Bert Quint, will present during the Wound Infections sessions hosted in Hall 4, SY 11, from 10.30 AM – 12.30 PM. He will talk about the clinical efficacy of our novel desiccant agent DEBRICHEM® in treating chronic skin wounds, and will be presenting a case series of 61 VLU patients.
We’re excited to finally be able to meet you all face to face. Our team is ready to welcome you at our booth in Hall 5, stand 141&A-11.
Curious about our product? Contact our team at info@debx-medical.com to make an appointment for an introduction during the conference.
